536 related articles for article (PubMed ID: 26627449)
21. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries.
Hardy AB; Varma R; Collyns T; Moffitt SJ; Mullarkey C; Watson JP
Thorax; 2010 Feb; 65(2):178-80. PubMed ID: 19996345
[TBL] [Abstract][Full Text] [Related]
22. Screening for active and latent tuberculosis among asylum seekers in Italy: A retrospective cohort analysis.
Pontarelli A; Marchese V; Scolari C; Capone S; El-Hamad I; Donato F; Moioli R; Girardi E; Cirillo DM; Castelli F; Matteelli A
Travel Med Infect Dis; 2019; 27():39-45. PubMed ID: 30347248
[TBL] [Abstract][Full Text] [Related]
23. Latent Tuberculosis Infection Testing Strategies for HIV-Positive Individuals in Hong Kong.
Wong NS; Chan KCW; Wong BCK; Leung CC; Chan WK; Lin AWC; Lui GCY; Mitchell KM; Lee SS
JAMA Netw Open; 2019 Sep; 2(9):e1910960. PubMed ID: 31490541
[TBL] [Abstract][Full Text] [Related]
24. Latent Tuberculosis Infection Among Immigrant and Refugee Children Arriving in the United States: 2010.
Taylor EM; Painter J; Posey DL; Zhou W; Shetty S
J Immigr Minor Health; 2016 Oct; 18(5):966-970. PubMed ID: 26364054
[TBL] [Abstract][Full Text] [Related]
25. Screening for Latent Tuberculosis Infection in Migrants With CKD: A Cost-effectiveness Analysis.
Campbell JR; Johnston JC; Ronald LA; Sadatsafavi M; Balshaw RF; Cook VJ; Levin A; Marra F
Am J Kidney Dis; 2019 Jan; 73(1):39-50. PubMed ID: 30269868
[TBL] [Abstract][Full Text] [Related]
26. Community treatment of latent tuberculosis in child and adult refugee populations: outcomes and successes.
Harwood-Johnson E; Leis KS; Hanson J; Olfert J; Blonde Y; Brindamour M
Front Public Health; 2023; 11():1225217. PubMed ID: 37942244
[TBL] [Abstract][Full Text] [Related]
27. Tuberculosis infection in under-2-year-old refugees: Should we be screening? A systematic review and meta-regression analysis.
Ghosh S; Dronavalli M; Raman S
J Paediatr Child Health; 2020 Apr; 56(4):622-629. PubMed ID: 31883282
[TBL] [Abstract][Full Text] [Related]
28. Domestic returns from investment in the control of tuberculosis in other countries.
Schwartzman K; Oxlade O; Barr RG; Grimard F; Acosta I; Baez J; Ferreira E; Melgen RE; Morose W; Salgado AC; Jacquet V; Maloney S; Laserson K; Mendez AP; Menzies D
N Engl J Med; 2005 Sep; 353(10):1008-20. PubMed ID: 16148286
[TBL] [Abstract][Full Text] [Related]
29. Assessment of postarrival tuberculosis examinations among immigrants and refugees screened overseas.
Gacek P; Sosa L; Lobato MN
Conn Med; 2013; 77(6):325-30. PubMed ID: 23923248
[TBL] [Abstract][Full Text] [Related]
30. Latent tuberculosis may be missed by current screening practices: Analysis of interferon-gamma release assay results from a paediatric refugee clinic.
Colgan K; Anderson J; Maycock A; Britton PN; Mackenzie M; Isaacs D; Gunasekera H
J Paediatr Child Health; 2019 Jul; 55(7):826-832. PubMed ID: 30565764
[TBL] [Abstract][Full Text] [Related]
31. Is Universal Screening Necessary? Incidence of Tuberculosis among Tibetan Refugees Arriving in Calgary, Alberta.
Lim R; Jarand J; Field SK; Fisher D
Can Respir J; 2016; 2016():8249843. PubMed ID: 28127230
[No Abstract] [Full Text] [Related]
32. The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review.
Greenaway C; Pareek M; Abou Chakra CN; Walji M; Makarenko I; Alabdulkarim B; Hogan C; McConnell T; Scarfo B; Christensen R; Tran A; Rowbotham N; van der Werf MJ; Noori T; Pottie K; Matteelli A; Zenner D; Morton RL
Euro Surveill; 2018 Apr; 23(14):. PubMed ID: 29637889
[TBL] [Abstract][Full Text] [Related]
33. Fewer losses in the cascade of care for latent tuberculosis with solo interferon-gamma release assay screening compared to sequential screening.
Lim RK; Talavlikar R; Chiazor O; Bietz J; Gardiner H; Fisher D
BMC Infect Dis; 2021 Sep; 21(1):936. PubMed ID: 34503458
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of tuberculosis evaluation and treatment of newly-arrived immigrants.
Porco TC; Lewis B; Marseille E; Grinsdale J; Flood JM; Royce SE
BMC Public Health; 2006 Jun; 6():157. PubMed ID: 16784541
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of latent tuberculosis infection in Syrian refugees to Canada.
Warrington P; Tyrrell G; Choy K; Eisenbeis L; Long R; Cooper R
Can J Public Health; 2018 Feb; 109(1):8-14. PubMed ID: 29981073
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of a school-based tuberculosis-screening program and associate investigation targeting recently immigrated children in a low-burden country.
Brassard P; Steensma C; Cadieux L; Lands LC
Pediatrics; 2006 Feb; 117(2):e148-56. PubMed ID: 16452324
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection.
Deuffic-Burban S; Atsou K; Viget N; Melliez H; Bouvet E; Yazdanpanah Y
Int J Tuberc Lung Dis; 2010 Apr; 14(4):471-81. PubMed ID: 20202306
[TBL] [Abstract][Full Text] [Related]
38. Screening for tuberculosis in migrants and visitors from high-incidence settings: present and future perspectives.
Dobler CC; Fox GJ; Douglas P; Viney KA; Ahmad Khan F; Temesgen Z; Marais BJ
Eur Respir J; 2018 Jul; 52(1):. PubMed ID: 29794133
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of latent tuberculous infection and treatment completion for refugees in Philadelphia, PA, 2010-2012.
Subedi P; Drezner KA; Dogbey MC; Newbern EC; Yun K; Scott KC; Garland JM; Altshuler MJ; Johnson CC
Int J Tuberc Lung Dis; 2015 May; 19(5):565-9. PubMed ID: 25868025
[TBL] [Abstract][Full Text] [Related]
40. Tuberculosis Among Foreign-Born Persons Diagnosed ≥10 Years After Arrival in the United States, 2010-2015.
Tsang CA; Langer AJ; Navin TR; Armstrong LR
MMWR Morb Mortal Wkly Rep; 2017 Mar; 66(11):295-298. PubMed ID: 28333913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
